Series A - EsoBiotec
Investment Firm
Overview
soBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.
Announced Date
Dec 12, 2023
Funding Type
Series A
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
EsoBiotec raised $2159699 on 2023-12-12 in Series A
soBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 12, 2023 |  Series A - EsoBiotec | 1 | - | 2.2M |
| Sep 30, 2021 | Seed Round - EsoBiotec | 4 | - | 3.5M |
| Sep 30, 2021 | Grant - EsoBiotec | 1 | - | 3.5M |
Recent Activity
There is no recent news or activity for this profile.